TickerFacts.

A business in context

PALI research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-19 · 0001493152-26-047944

  2. 4 · Ownership change

    Report date 2026-10-06 · 0001493152-26-046202

  3. 4 · Ownership change

    Report date 2026-10-06 · 0001493152-26-046201

  4. 4 · Ownership change

    Report date 2026-10-01 · 0001493152-26-045772

  5. 4 · Ownership change

    Report date 2026-08-19 · 0001493152-26-039746

  6. 8-K · Current report

    Report date 2026-08-10 · 0001357459-26-000017 · Items 2.02,9.01

  7. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001357459-26-000016

  8. 4 · Ownership change

    Report date 2026-07-08 · 0001493152-26-032884

  9. 4 · Ownership change

    Report date 2026-07-06 · 0001493152-26-032563

  10. 4 · Ownership change

    Report date 2026-07-06 · 0001493152-26-032561

  11. 8-K · Current report

    Report date 2026-06-10 · 0001493152-26-028322 · Items 5.02,5.03,5.07,9.01

  12. 8-K · Current report

    Report date 2026-05-12 · 0001357459-26-000011 · Items 2.02,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001357459-26-000010

  14. DEF 14A · Proxy statement

    Report date 2026-04-29 · 0001493152-26-019629

  15. 8-K · Current report

    Report date 2026-03-27 · 0001493152-26-014822 · Items 8.01

  16. 10-K · Annual report

    Report date 2025-12-31 · 0001357459-26-000004

  17. 8-K · Current report

    Report date 2025-12-03 · 0001493152-25-026195 · Items 5.03,5.07,9.01

  18. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-274262

  19. DEF 14A · Proxy statement

    Report date 2025-10-28 · 0001493152-25-019900

  20. 8-K · Current report

    Report date 2025-10-21 · 0001493152-25-018922 · Items 5.02

  21. 8-K · Current report

    Report date 2025-10-17 · 0001493152-25-018684 · Items 5.07

  22. 8-K · Current report

    Report date 2025-10-15 · 0001493152-25-018324 · Items 8.01

  23. 8-K · Current report

    Report date 2025-10-09 · 0001493152-25-017630 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2025-09-26 · 0001493152-25-015775 · Items 8.01

  25. 8-K · Current report

    Report date 2025-09-18 · 0001493152-25-014071 · Items 8.01

  26. DEF 14A · Proxy statement

    Report date 2025-09-15 · 0001493152-25-013379

  27. 8-K · Current report

    Report date 2025-09-04 · 0001493152-25-012687 · Items 5.02

  28. DEF 14A · Proxy statement

    Report date 2025-08-18 · 0001641172-25-024628

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-106587

  30. 8-K · Current report

    Report date 2025-07-23 · 0001641172-25-020896 · Items 1.01,3.02,8.01,9.01

  31. 8-K · Current report

    Report date 2025-07-02 · 0001641172-25-018313 · Items 5.02,8.01,9.01

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-069204

  33. 8-K · Current report

    Report date 2025-04-29 · 0001641172-25-008346 · Items 3.01

  34. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-043859

  35. 8-K · Current report

    Report date 2024-12-16 · 0001493152-24-050203 · Items 1.01,3.02,8.01,9.01

  36. SC 13G · Ownership disclosure

    0001172661-24-005101

  37. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-124664

  38. 8-K · Current report

    Report date 2024-09-27 · 0001493152-24-038547 · Items 1.01,5.02,9.01

  39. 10-Q · Quarterly report

    Report date 2024-06-30 · 0000950170-24-095432

  40. 8-K · Current report

    Report date 2024-07-08 · 0001493152-24-026504 · Items 5.07

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 6 transaction rows6PSale: 2 transaction rows2SGrant / award: 0 transaction rows0AExercise / conversion: 6 transaction rows6MTax / exercise payment: 0 transaction rows0FGift: 2 transaction rows2G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

16 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-19
2026-08-21
Finley John DavidG · Gift
Acquired
Common Stock88400.00.0
2026-08-19
2026-08-21
Finley John DavidG · Gift
Disposed
Common Stock88400.00.0
2026-07-09
2026-07-10
Baltera Robert Jr.P · Purchase
Acquired
Common Stock25000.01.96
2026-07-08
2026-07-10
Baltera Robert Jr.P · Purchase
Acquired
Common Stock20000.01.99
2026-07-07
2026-07-08
Baltera Robert Jr.P · Purchase
Acquired
Common Stock30000.02.03
2026-07-07
2026-07-08
Jones Mitchell LawrenceS · Sale
Disposed
Common Stock51880.02.05
2026-07-07
2026-07-08
Finley John DavidM · Exercise / conversion
Acquired
Common Stock133.00.7
2026-07-07
2026-07-08
Finley John DavidS · Sale
Disposed
Common Stock146798.02.07
2026-07-07
2026-07-08
Finley John DavidM · Exercise / conversion
Disposed
Series 2 Common Stock Purchase Warrant
Derivative security
133.00.0
2026-07-06
2026-07-08
Baltera Robert Jr.P · Purchase
Acquired
Common Stock20000.02.05
2026-07-06
2026-07-08
Jones Mitchell LawrenceM · Exercise / conversion
Acquired
Common Stock131167.0n/a
2026-07-06
2026-07-08
Jones Mitchell LawrenceM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
131167.00.0
2026-07-06
2026-07-08
Finley John DavidM · Exercise / conversion
Acquired
Common Stock335167.0n/a
2026-07-06
2026-07-08
Finley John DavidM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
335167.00.0
2026-07-02
2026-07-06
Baltera Robert Jr.P · Purchase
Acquired
Common Stock10000.01.98
2026-07-01
2026-07-06
Baltera Robert Jr.P · Purchase
Acquired
Common Stock20000.01.98

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001357459PALISADE BIO, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • PALISADE BIO, INC. · former SEC name · 2021-04-27 to 2026-10-21
  • Seneca Biopharma, Inc. · former SEC name · 2020-01-28 to 2021-04-26
  • Neuralstem, Inc. · former SEC name · 2006-04-03 to 2020-01-23

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$0$0
2023-12-31$300.0K$331.7K
2020-12-31$13.5K$17.6K
2019-12-31$15.4K$20.3K
2018-12-31$260.0K$348.9K
2017-12-31$260.0K$357.4K

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗